Published in EMBO J on November 17, 1997
Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry (2001) 3.62
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. Proc Natl Acad Sci U S A (2009) 2.86
Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Proc Natl Acad Sci U S A (2001) 2.58
G protein coupled receptor structure and activation. Biochim Biophys Acta (2006) 2.48
Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors. Proc Natl Acad Sci U S A (2009) 2.01
Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer. EMBO J (2009) 1.86
The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. Biophys J (1999) 1.82
Serine and threonine residues bend alpha-helices in the chi(1) = g(-) conformation. Biophys J (2000) 1.57
Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. Structure (2011) 1.54
Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias. J Biol Chem (2010) 1.46
Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes. Annu Rev Pharmacol Toxicol (2008) 1.41
Efficacy of the β₂-adrenergic receptor is determined by conformational equilibrium in the transmembrane region. Nat Commun (2012) 1.40
Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. Biophys J (2007) 1.37
G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. Curr Opin Drug Discov Devel (2001) 1.33
Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions. Biophys J (2000) 1.32
The structural basis of G-protein-coupled receptor signaling (Nobel Lecture). Angew Chem Int Ed Engl (2013) 1.25
Conformational changes in G-protein-coupled receptors-the quest for functionally selective conformations is open. Br J Pharmacol (2007) 1.23
Structural insights into G-protein-coupled receptor activation. Curr Opin Struct Biol (2008) 1.22
G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient. J Biol Chem (2011) 1.21
Interaction and conformational dynamics of membrane-spanning protein helices. Protein Sci (2009) 1.19
Homology modeling of opioid receptor-ligand complexes using experimental constraints. AAPS J (2005) 1.18
Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. Proc Natl Acad Sci U S A (1999) 1.16
Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol Endocrinol (2007) 1.12
Comparative sequence and structural analyses of G-protein-coupled receptor crystal structures and implications for molecular models. PLoS One (2009) 1.12
Structural and functional consequences of the cardiac troponin C L48Q Ca(2+)-sensitizing mutation. Biochemistry (2012) 1.11
Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization. Biochemistry (2006) 1.09
Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers. AAPS J (2006) 1.09
Calcium-sensitive regions of GCAP1 as observed by chemical modifications, fluorescence, and EPR spectroscopies. J Biol Chem (2001) 1.07
Modeling activated states of GPCRs: the rhodopsin template. J Comput Aided Mol Des (2006) 1.06
Modeling the human PTC bitter-taste receptor interactions with bitter tastants. J Mol Model (2006) 1.05
Single-cell analysis of G-protein signal transduction. J Biol Chem (2015) 1.04
Light activation of rhodopsin: insights from molecular dynamics simulations guided by solid-state NMR distance restraints. J Mol Biol (2009) 1.01
Influence of the environment in the conformation of alpha-helices studied by protein database search and molecular dynamics simulations. Biophys J (2002) 1.01
Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation. J Biol Chem (2007) 1.00
Self-compatible B mutants in coprinus with altered pheromone-receptor specificities. Genetics (2000) 1.00
Constitutive activation of the neurotensin receptor 1 by mutation of Phe(358) in Helix seven. Br J Pharmacol (2002) 0.99
Rod monochromacy and the coevolution of cetacean retinal opsins. PLoS Genet (2013) 0.98
The cytoplasmic end of transmembrane domain 3 regulates the activity of the Saccharomyces cerevisiae G-protein-coupled alpha-factor receptor. Genetics (2002) 0.96
The role of the 3-hydroxy 3-methylglutaryl coenzyme A reductase cytosolic domain in karmellae biogenesis. Mol Biol Cell (1999) 0.96
Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors. J Comput Aided Mol Des (2006) 0.95
A proposed structure for transmembrane segment 7 of G protein-coupled receptors incorporating an asn-Pro/Asp-Pro motif. Biophys J (1998) 0.93
What site-directed labeling studies tell us about the mechanism of rhodopsin activation and G-protein binding. Photochem Photobiol Sci (2010) 0.90
Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor. Br J Pharmacol (2007) 0.90
A constitutively activating mutation alters the dynamics and energetics of a key conformational change in a ligand-free G protein-coupled receptor. J Biol Chem (2013) 0.89
Green light to illuminate signal transduction events. Trends Cell Biol (2009) 0.89
Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation. EMBO J (2000) 0.87
Bioorthogonal fluorescent labeling of functional G-protein-coupled receptors. Chembiochem (2014) 0.87
Substrate-induced Unlocking of the Inner Gate Determines the Catalytic Efficiency of a Neurotransmitter:Sodium Symporter. J Biol Chem (2015) 0.86
Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors. Biochim Biophys Acta (2013) 0.86
Allosteric activation of the CaR by L-amino acids. Proc Natl Acad Sci U S A (2000) 0.83
Structural and functional roles of small group-conserved amino acids present on helix-H7 in the β(2)-adrenergic receptor. Biochim Biophys Acta (2011) 0.82
New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket. Br J Pharmacol (2004) 0.82
Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor. Br J Pharmacol (2001) 0.81
Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors. J Chem Inf Model (2011) 0.80
Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices. Proc Natl Acad Sci U S A (2016) 0.80
Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor. Proteins (2010) 0.79
Rhodopsin's active state is frozen like a DEER in the headlights. Proc Natl Acad Sci U S A (2008) 0.77
Docking of human rhodopsin mutant (Gly90→Asp) with beta-arrestin and cyanidin 3-rutinoside to cure night blindness. Bioinformation (2012) 0.77
Investigation of D₂ receptor-agonist interactions using a combination of pharmacophore and receptor homology modeling. ChemMedChem (2012) 0.77
AT1 mutations and risk of atrial fibrillation based on genotypes from 71,000 individuals from the general population. Br J Clin Pharmacol (2013) 0.77
Genetically-encoded molecular probes to study G protein-coupled receptors. J Vis Exp (2013) 0.76
Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation. J Mol Model (2014) 0.76
Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2 -adrenoceptor. Br J Pharmacol (2015) 0.76
On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers. J Recept Signal Transduct Res (2010) 0.76
Investigation of D₁ receptor-agonist interactions and D₁/D₂ agonist selectivity using a combination of pharmacophore and receptor homology modeling. ChemMedChem (2012) 0.76
The essential role for aromatic cluster in the β3 adrenergic receptor. Acta Pharmacol Sin (2012) 0.75
TSH Receptor Signaling Abrogation by a Novel Small Molecule. Front Endocrinol (Lausanne) (2016) 0.75
N-terminal fusion tags for effective production of g-protein-coupled receptors in bacterial cell-free systems. Acta Naturae (2012) 0.75
Effect of a toggle switch mutation in TM6 of the human adenosine A₃ receptor on Gi protein-dependent signalling and Gi-independent receptor internalization. Br J Pharmacol (2014) 0.75
Mechanistic insights into GPCR-G protein interactions. Curr Opin Struct Biol (2016) 0.75
In-Membrane Chemical Modification (IMCM) for Site-Specific Chromophore Labeling of GPCRs. Angew Chem Int Ed Engl (2015) 0.75
Sporadic congenital nonautoimmune hyperthyroidism caused by P639S mutation in thyrotropin receptor gene. Eur J Pediatr (2012) 0.75
Dynamic Roles for the N-terminus of the Yeast G Protein-Coupled Receptor Ste2p. Biochim Biophys Acta (2017) 0.75
Benzimidazole derivatives. 4. The recognition of the voluminous substituent attached to the basic amino group of 5-HT4 receptor antagonists. J Comput Aided Mol Des (2003) 0.75
Optimization by simulated annealing. Science (1983) 71.02
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (1996) 26.19
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell (1996) 17.13
Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science (1996) 6.50
A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem (1993) 4.52
The probable arrangement of the helices in G protein-coupled receptors. EMBO J (1993) 3.57
Projection structure of rhodopsin. Nature (1993) 3.41
Structure and function of G protein-coupled receptors. Annu Rev Biochem (1994) 3.36
Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol (1992) 2.97
Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem (1989) 2.95
Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal Biochem (1995) 2.62
Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci (1993) 2.59
Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature (1996) 2.55
In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem J (1992) 2.14
Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. Proc Natl Acad Sci U S A (1996) 2.08
Adrenergic receptors as models for G protein-coupled receptors. Annu Rev Neurosci (1992) 2.04
Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem (1997) 2.01
G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci U S A (1991) 1.90
Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. Biochemistry (1996) 1.88
Mapping of the amino acids in membrane-embedded helices that interact with the retinal chromophore in bovine rhodopsin. J Biol Chem (1991) 1.80
Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J (1996) 1.74
Allele-specific activation of genetically engineered receptors. J Biol Chem (1991) 1.72
Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. J Biol Chem (1992) 1.64
A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J Biol Chem (1994) 1.63
Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Opin Biotechnol (1994) 1.54
Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. J Biol Chem (1995) 1.52
The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines. J Biol Chem (1994) 1.49
Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem (1989) 1.45
The mammalian beta 2-adrenergic receptor: purification and characterization. Biochemistry (1984) 1.45
Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. Biochemistry (1990) 1.41
Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites. J Biol Chem (1996) 1.37
Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. Biochemistry (1995) 1.37
Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method. Neuron (1995) 1.27
Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells. J Biol Chem (1992) 1.27
Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. EMBO J (1991) 1.25
A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol (1994) 1.25
Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J Med Chem (1992) 1.23
Site-directed mutagenesis of beta-adrenergic receptors. Identification of conserved cysteine residues that independently affect ligand binding and receptor activation. J Biol Chem (1989) 1.21
Evidence for essential disulfide bonds in beta1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol. J Biol Chem (1979) 1.10
The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci U S A (1997) 1.08
Biophysical and genetic analysis of the ligand-binding site of the beta-adrenoceptor. Trends Pharmacol Sci (1991) 1.04
Three-dimensional structure for the beta 2 adrenergic receptor protein based on computer modeling studies. J Mol Biol (1992) 1.04
Modeling of transmembrane seven helix bundles. Protein Eng (1993) 1.03
Ligand-induced domain motion in the activation mechanism of a G-protein-coupled receptor. Protein Eng (1994) 1.03
Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering. EMBO J (1996) 0.95
Arrangement of transmembrane domains in adrenergic receptors. Similarity to bacteriorhodopsin. J Biol Chem (1996) 0.93
Signal transduction by a 5-HT2 receptor: a mechanistic hypothesis from molecular dynamics simulations of the three-dimensional model of the receptor complexed to ligands. J Med Chem (1993) 0.92
Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. Mol Pharmacol (1995) 0.91
Mutational analysis of the relative orientation of transmembrane helices I and VII in G protein-coupled receptors. J Biol Chem (1995) 0.87
Identification of intramolecular interactions in adrenergic receptors. J Biol Chem (1992) 0.85
Molecular dynamics simulations of m3-muscarinic receptor activation and QSAR analysis. Bioorg Med Chem (1995) 0.83
Modeling of G-protein coupled receptors with bacteriorhodopsin as a template. A novel approach based on interaction energy differences. J Recept Res (1994) 0.79
Carazolol: a potent, selective beta 3-adrenoceptor agonist. Eur J Pharmacol (1995) 0.79
Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature (1986) 7.06
Evaluation of coliform tests for chlorinated secondary effluents. J Water Pollut Control Fed (1973) 5.51
Synthetic lac operator DNA is functional in vivo. Nature (1976) 5.36
Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci U S A (1987) 4.66
cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A (1987) 4.61
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol (1989) 4.30
HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J (2000) 4.11
Presence of an SH2 domain in the actin-binding protein tensin. Science (1991) 4.03
Dynamics and segregation of cell-matrix adhesions in cultured fibroblasts. Nat Cell Biol (2000) 3.99
The general affinity of lac repressor for E. coli DNA: implications for gene regulation in procaryotes and eucaryotes. Cell (1975) 3.73
Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac. Nat Genet (2001) 3.65
Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry (1996) 3.65
Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem (1996) 3.63
T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A (1998) 3.61
Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J Biol Chem (1980) 3.49
Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J Biol Chem (2001) 3.41
An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature (1987) 3.33
Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am J Physiol Heart Circ Physiol (2000) 3.32
Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc Natl Acad Sci U S A (1988) 3.18
Integrin dynamics and matrix assembly: tensin-dependent translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis. J Cell Biol (2000) 3.13
Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol In Vitro (2014) 3.10
Beta-galactosidase. Rates of synthesis and degradation of incomplete chains. J Biol Chem (1972) 3.06
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor. J Biol Chem (2001) 2.95
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A (2001) 2.95
G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem (1998) 2.92
Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med (1999) 2.92
Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J Biol Chem (1992) 2.91
Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc Natl Acad Sci U S A (1988) 2.78
Cytochalasins inhibit nuclei-induced actin polymerization by blocking filament elongation. J Cell Biol (1980) 2.74
Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem (1999) 2.73
Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science (1996) 2.71
Cytochalasin B, its interaction with actin and actomyosin from muscle (cell movement-microfilaments-rabbit striated muscle). Proc Natl Acad Sci U S A (1972) 2.68
The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the beta 2-adrenergic receptor. J Biol Chem (2000) 2.67
Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature (1981) 2.63
The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut (1999) 2.60
Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Proc Natl Acad Sci U S A (2001) 2.58
Lipid A modifications characteristic of Salmonella typhimurium are induced by NH4VO3 in Escherichia coli K12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate. J Biol Chem (1999) 2.56
Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature (1999) 2.55
Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A (2001) 2.52
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature (1995) 2.51
GATA-1 expression pattern can be recapitulated in living transgenic zebrafish using GFP reporter gene. Development (1997) 2.38
Specific interaction of vinculin with alpha-actinin. Biochem Biophys Res Commun (1987) 2.34
A comparison of lac repressor binding to operator and to nonoperator DNA. Biochem Biophys Res Commun (1975) 2.32
Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation. J Biol Chem (2001) 2.30
A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Pharmacogenomics J (2010) 2.30
Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J (1998) 2.29
Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem (1999) 2.28
Bacterial activity in South Pole snow. Appl Environ Microbiol (2000) 2.28
The peptide product of a 5' leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J Biol Chem (1994) 2.27
Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J Biol Chem (1987) 2.20
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood (1996) 2.19
Toward a resolution of the introns early/late debate: only phase zero introns are correlated with the structure of ancient proteins. Proc Natl Acad Sci U S A (1998) 2.16
The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol (2001) 2.15
Zebrafish pigmentation mutations and the processes of neural crest development. Development (1996) 2.14
The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature (1988) 2.13
Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. Mol Biol Cell (1999) 2.10
Purification and initial characterization of a protein from skeletal muscle that caps the barbed ends of actin filaments. J Biol Chem (1986) 2.08
Hinges, swivels and switches: the role of prolines in signalling via transmembrane alpha-helices. Trends Pharmacol Sci (2000) 2.08
Neurological impairment in violent schizophrenic inpatients. Am J Psychiatry (1989) 2.07
Neuropathology in mice expressing human alpha-synuclein. J Neurosci (2000) 2.06
Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity (1997) 2.04
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci U S A (1996) 2.02
Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem (1997) 2.01
Actin polymerization induced by a motility-related high-affinity cytochalasin binding complex from human erythrocyte membrane. Proc Natl Acad Sci U S A (1979) 1.99
Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. J Biol Chem (1999) 1.97
Timing, propagation, coordination, and effect of esophageal shortening during peristalsis. Gastroenterology (1997) 1.94
The RAD50 gene, a member of the double strand break repair epistasis group, is not required for spontaneous mitotic recombination in yeast. Curr Genet (1990) 1.93
Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nat Biotechnol (1998) 1.92
Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res (1996) 1.88
Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature (1988) 1.88
Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med (2005) 1.88
Biochemical studies on the mode of action of cytochalasin B. Cytochalasin B binding to red cell membrane in relation to glucose transport. J Biol Chem (1974) 1.86
High-affinity interaction of vinculin with actin filaments in vitro. Cell (1982) 1.83
The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. Biophys J (1999) 1.82
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol (1997) 1.80
(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem (1994) 1.80
Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A (1997) 1.78
GPCR-Galpha fusion proteins: molecular analysis of receptor-G-protein coupling. Trends Pharmacol Sci (1999) 1.78
Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol (1999) 1.77
Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, A new Fe2+/alpha-ketoglutarate-dependent dioxygenase homologue. J Biol Chem (2000) 1.76
The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. Med Phys (1995) 1.75
Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med (2003) 1.74
Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2. Curr Opin Lipidol (2001) 1.70
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am (2006) 1.70
The RNA polymerase II elongation complex. Factor-dependent transcription elongation involves nascent RNA cleavage. J Biol Chem (1992) 1.69
Closure mechanisms of laryngeal vestibule during swallow. Am J Physiol (1992) 1.67
An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature (2001) 1.65
Outcome in schizophrenia and related disorders compared between developing and developed countries. A recursive partitioning re-analysis of the WHO DOSMD data. Br J Psychiatry (1997) 1.65
Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. J Biol Chem (1992) 1.64
Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams. Phys Med Biol (2005) 1.64
Multiple second messenger pathways of alpha-adrenergic receptor subtypes expressed in eukaryotic cells. J Biol Chem (1990) 1.64
Shape, volume, and content of the deglutitive pharyngeal chamber imaged by ultrafast computerized tomography. Gastroenterology (1993) 1.63
A zebrafish model for hepatoerythropoietic porphyria. Nat Genet (1998) 1.62
Specificity of the effects of cytochalasin B on transport and motile processes. Proc Natl Acad Sci U S A (1978) 1.61
Accumulation of a polyisoprene-linked amino sugar in polymyxin-resistant Salmonella typhimurium and Escherichia coli: structural characterization and transfer to lipid A in the periplasm. J Biol Chem (2001) 1.60
Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem (1994) 1.60